Jörg Kreuter

18.0k total citations · 3 hit papers
154 papers, 13.7k citations indexed

About

Jörg Kreuter is a scholar working on Biomaterials, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Jörg Kreuter has authored 154 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Biomaterials, 54 papers in Molecular Biology and 40 papers in Pharmaceutical Science. Recurrent topics in Jörg Kreuter's work include Nanoparticle-Based Drug Delivery (57 papers), Advanced Drug Delivery Systems (32 papers) and RNA Interference and Gene Delivery (21 papers). Jörg Kreuter is often cited by papers focused on Nanoparticle-Based Drug Delivery (57 papers), Advanced Drug Delivery Systems (32 papers) and RNA Interference and Gene Delivery (21 papers). Jörg Kreuter collaborates with scholars based in Germany, Russia and Switzerland. Jörg Kreuter's co-authors include Svetlana Gelperina, R. N. Alyautdin, Hagen von Briesen, Klaus Langer, В Е Петров, David J. Begley, Peter Ramge, Andreas Zimmer, Telli Hekmatara and A. S. Khalansky and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biomaterials.

In The Last Decade

Jörg Kreuter

153 papers receiving 13.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier

2002 633 citations Jörg Kreuter, R. N. Alyautdin et al. Journal of drug targeting profile →
Transport of drugs across the blood–brain barrier by nanoparticles

2011 536 citations Svetlana Gelperina, Jörg Kreuter et al. Journal of Controlled Release profile →
Nanoparticulate systems for brain delivery of drugs

2012 465 citations Jörg Kreuter profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jörg Kreuter Germany	61	6.9k	5.0k	3.9k	3.2k	1.5k	154	13.7k
Xinguo Jiang China	67	6.0k 0.9×	5.8k 1.2×	2.3k 0.6×	4.5k 1.4×	1.8k 1.2×	168	13.5k
Vinod Labhasetwar United States	61	8.4k 1.2×	7.0k 1.4×	3.8k 1.0×	5.4k 1.7×	2.9k 1.9×	148	18.9k
Zhirong Zhang China	75	6.0k 0.9×	8.2k 1.6×	3.4k 0.9×	5.3k 1.7×	1.5k 1.0×	525	19.1k
Elena V. Batrakova United States	57	5.1k 0.7×	8.4k 1.7×	1.9k 0.5×	3.0k 1.0×	1.4k 0.9×	107	15.8k
S. Moein Moghimi United Kingdom	68	8.7k 1.3×	8.4k 1.7×	2.5k 0.6×	5.5k 1.7×	2.6k 1.8×	217	19.0k
Jörg Huwyler Switzerland	56	2.9k 0.4×	4.7k 0.9×	1.4k 0.4×	2.5k 0.8×	1.1k 0.7×	277	12.3k
Zhiqing Pang China	66	5.5k 0.8×	5.8k 1.2×	1.1k 0.3×	5.6k 1.8×	1.7k 1.2×	176	13.2k
Arto Urtti Finland	66	2.6k 0.4×	7.6k 1.5×	4.9k 1.3×	2.3k 0.7×	829 0.6×	418	17.9k
Fatemeh Atyabi Iran	63	5.5k 0.8×	4.5k 0.9×	3.0k 0.8×	3.6k 1.1×	1.3k 0.9×	331	13.2k
Qiang Zhang China	76	7.5k 1.1×	9.4k 1.9×	2.8k 0.7×	6.1k 1.9×	2.0k 1.4×	402	19.2k

Countries citing papers authored by Jörg Kreuter

Since Specialization

Citations

This map shows the geographic impact of Jörg Kreuter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Kreuter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Kreuter more than expected).

Fields of papers citing papers by Jörg Kreuter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Kreuter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Kreuter. The network helps show where Jörg Kreuter may publish in the future.

Co-authorship network of co-authors of Jörg Kreuter

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg Kreuter. A scholar is included among the top collaborators of Jörg Kreuter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg Kreuter. Jörg Kreuter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tosi, Giovanni, Jason Thomas Duskey, & Jörg Kreuter. (2019). Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier. Expert Opinion on Drug Delivery. 17(1). 23–32. 105 indexed citations

Malinovskaya, Julia, Pavel Melnikov, Владимир П. Баклаушев, et al.. (2017). Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells. International Journal of Pharmaceutics. 524(1-2). 77–90. 140 indexed citations

Kreuter, Jörg. (2015). Influence of Chronobiology on the Nanoparticle-Mediated Drug Uptake into the Brain. Pharmaceutics. 7(1). 3–9. 13 indexed citations

Wagner, Sylvia, et al.. (2014). Freeze-drying of HI-6-loaded recombinant human serum albumin nanoparticles for improved storage stability. European Journal of Pharmaceutics and Biopharmaceutics. 88(2). 510–517. 29 indexed citations

Khalansky, A. S., et al.. (2011). Kinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrier. Journal of Controlled Release. 154(1). 103–107. 84 indexed citations

Kreuter, Jörg, et al.. (2011). Characterisation and stability studies of a hydrophilic decapeptide in different adjuvant drug delivery systems: A comparative study of PLGA nanoparticles versus chitosan-dextran sulphate microparticles versus DOTAP-liposomes. International Journal of Pharmaceutics. 421(1). 151–159. 17 indexed citations

Tahara, Kohei, et al.. (2010). Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells. Journal of Microencapsulation. 28(1). 29–36. 20 indexed citations

Wagner, Sylvia, et al.. (2008). Specific Targeting of HER2 Overexpressing Breast Cancer Cells with Doxorubicin-Loaded Trastuzumab-Modified Human Serum Albumin Nanoparticles. Bioconjugate Chemistry. 19(12). 2321–2331. 110 indexed citations

Gelperina, Svetlana, et al.. (2006). Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effect of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model. Journal of Microencapsulation. 23(5). 582–592. 85 indexed citations

10.

Weber, Carolin, et al.. (2005). Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes. Biomaterials. 26(29). 5898–5906. 173 indexed citations

11.

Kreuter, Jörg. (2004). Influence of the Surface Properties on Nanoparticle-Mediated Transport of Drugs to the Brain. Journal of Nanoscience and Nanotechnology. 4(5). 484–488. 266 indexed citations

12.

Lochmann, Dirk, et al.. (2004). Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation. Journal of Controlled Release. 96(3). 497–507. 37 indexed citations

13.

Vogel, Vitali, et al.. (2003). Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 57(2). 369–375. 314 indexed citations

14.

Begley, David J. & Jörg Kreuter. (2002). Preface. Journal of drug targeting. 10(4). 261–262. 1 indexed citations

15.

Michaelis, Martin, Josef Matoušek, Jens‐Uwe Vogel, et al.. (2000). Bovine seminal ribonuclease attached to nanoparticles made of polylactic acid kills leukemia and lymphoma cell lines in vitro. Anti-Cancer Drugs. 11(5). 369–376. 24 indexed citations

16.

Löbenberg, Raimar & Jörg Kreuter. (1996). Macrophage Targeting of Azidothymidine: A Promising Strategy for AIDS Therapy*. AIDS Research and Human Retroviruses. 12(18). 1709–1715. 55 indexed citations

17.

Kreuter, Jörg, R. N. Alyautdin, D. A. Kharkevich, & Ivanov Aa. (1995). Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Research. 674(1). 171–174. 428 indexed citations

18.

Kreuter, Jörg, et al.. (1992). Influence of the surface properties of low contact angle surfactants on the body distribution of¹⁴C-poly(methyl methacrylate) nanoparticles. Journal of Microencapsulation. 9(1). 19–28. 49 indexed citations

19.

Kreuter, Jörg. (1988). Possibilities of using nanoparticles as carriers for drugs and vaccines. Journal of Microencapsulation. 5(2). 115–127. 49 indexed citations

20.

Kreuter, Jörg, et al.. (1986). Ocular drug delivery of progesterone using nanoparticles. Journal of Microencapsulation. 3(3). 213–218. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact